Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Arsalan Arif, founder of Endpoints News, for a wide-ranging conversation on the business of biotech. From his early days bootstrapping a media company to Endpoints’ recent partnership with the Financial Times, Arsalan shares his journey and reflections on what it takes to build trust in an evolving industry. Together, they unpack today’s cell and gene therapy landscape, where clinical success alone isn’t enough. Arsalan offers his perspective on investor sentiment, why scaling remains the biggest challenge in CGT, and how economic models, not efficacy, will shape the next chapter of growth. Learn more about Arsalan:

You can listen to Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success online on Radio and Podcast. Open the player on this page to stream the available audio.

Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success is an episode from Ori Spotlight by Ori Biotech.

This episode is 00:47:48 long.

This episode was published on Jul 1, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Ori Spotlight when more episodes are available from the podcast feed.